Smart Inhalers Global Market Report 2024

Description

Smart inhalers are medical devices that incorporate connectivity with a mobile app, often through Bluetooth technology. These devices are designed to improve the user experience and offer more personalized treatment decisions for individuals dealing with chronic lung conditions, including asthma and chronic obstructive pulmonary disease (COPD). Smart inhalers aim to enhance medication adherence, monitor inhaler usage, and provide valuable insights into the patient's respiratory health through the integration of digital technologies.

The primary types of smart inhalers include dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). Dry powdered inhalers (DPIs) are a specific type of inhaler designed to deliver medications, including inhaled corticosteroids, directly into the lungs. These inhalers are utilized in the treatment of various conditions such as asthma, chronic obstructive pulmonary disease (COPD), and others. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies. Smart inhalers, including DPIs, are employed by various end-users, including hospitals, homecare settings, and other healthcare facilities.

The smart inhalers market research report is one of a series of new reports from The Business Research Company that provides smart inhalers market statistics, including smart inhalers industry global market size, regional shares, competitors with a smart inhalers market share, detailed smart inhalers market segments, market trends, and opportunities, and any further data you may need to thrive in the smart inhalers industry. This smart inhalers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart inhalers market size has grown strongly in recent years. It will grow from $1.48 billion in 2023 to $1.62 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth observed in the historical period can be attributed to factors such as increased medical adherence among patients, a growing emphasis on patient-centric healthcare, and an increasing demand for connected healthcare devices. These elements collectively contributed to the adoption and expansion of smart inhalers during the historic period, reflecting a trend towards more patient-engaged and technology-enabled healthcare solutions.

The smart inhalers market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period for smart inhalers can be attributed to factors such as the rising prevalence of chronic respiratory diseases (CRDs), an increasing demand for home healthcare solutions, and the growing adoption of digital healthcare technologies. Major trends expected in the forecast period include technological advancements in smart inhalers, the utilization of big data analytics for respiratory health management, the incorporation of chip-on-sensors, and advancements in sensor technology, all of which contribute to the evolution of more effective and patient-friendly respiratory care solutions.

The increasing prevalence of chronic respiratory diseases (CRDs) is set to drive the growth of the smart inhaler market. Chronic respiratory diseases encompass a range of long-term conditions affecting the airways and lungs. Smart inhalers play a vital role in managing CRDs such as asthma and COPD by tracking usage and providing reminders for medication doses. This ensures consistent medication use, aiding in symptom control and preventing exacerbations. In Australia, respiratory disease-related deaths increased from 43,031 in 2020 to 46,551 in 2021, as reported by the Australian Institute of Health and Welfare in June 2023. Additionally, data from The Lancet in September 2022 revealed 11,255 new cases of respiratory syncytial virus (RSV) in 2021. The rising prevalence of CRDs is a significant driver for the smart inhaler market.

Major companies in the smart inhaler market are actively developing advanced technologies, such as digital respiratory health solutions, to cater to larger customer bases, increase sales, and boost revenue. Digital respiratory health solutions refer to technological interventions or platforms designed to address and manage respiratory health conditions through digital means. In February 2022, Aptar Pharma introduced the HeroTracker Sense, an add-on connected device serving as a digital respiratory health solution. This device transforms standard metered-dose inhalers (MDIs) into smart connected healthcare devices, focusing on improving the lives of patients with chronic respiratory diseases. HeroTracker Sense, attached to the MDI canister, features sensors to track inhalation coordination, flow rate, and duration. It provides information through a companion app, offering medication reminders with date and time stamps, along with environmental monitoring alerts such as temperature and humidity. The device aims to enhance patient adherence to prescribed therapies by facilitating informed and compliant medication intake.

In August 2022, AptarGroup Inc. acquired worldwide rights to the proprietary Orbital dry powder inhaler (DPI) from Pharmaxis Inc. for an undisclosed amount. Orbital technology is designed to deliver high-payload dry powder to the lungs without the need to reload, allowing patients to inhale powder payloads of up to 400mg in divided doses. This strategic acquisition strengthens Aptar Pharma's position in respiratory drug delivery devices and associated services. Pharmaxis Inc., an Australia-based pharmaceutical company, specializes in the development of dry powder inhalers (DPIs).

Major companies operating in the smart inhalers market report are Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc., 3M Health Care Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Group Inc., Aptar Group Inc., Lupin Limited, Findair Sp.Z.o.o., OPKO Health Inc., Nemera France SAS, Vectura Group Limited, Propeller Health, Inspiro Medical Ltd., Biocorp Production, Cohero Health Inc., Pneuma Respiratory Inc., Amiko Digital Health Limited, Cognita Labs LLC, AireHealth Inc., Adherium Ltd., Zeolr Technologies Pvt Ltd., H&T Presspart Manufacturing Ltd.

North America was the largest region in the smart inhalers market in 2023. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart inhalers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart inhalers market consists of sales of pressurized MDIs (metered-dose inhalers), breath-actuated MDIs (metered-dose inhalers), and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Inhalers Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart inhalers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart inhalers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart inhalers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Dry Powdered Inhalers (DPIs); Metered Dose Inhalers (MDIs)
2) By Indication: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Other Indications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End-User: Hospitals; Homecare Settings; Other End-Users
Companies Mentioned: Novartis AG; AstraZeneca Plc; GlaxoSmithKline Plc.; 3M Health Care Limited; Boehringer Ingelheim International GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r16922

1. Executive Summary

2. Smart Inhalers Market Characteristics

3. Smart Inhalers Market Trends And Strategies

4. Smart Inhalers Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Smart Inhalers Market Size and Growth

5.1. Global Smart Inhalers Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Smart Inhalers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Smart Inhalers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Inhalers Market Segmentation

6.1. Global Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Dry Powdered Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
6.2. Global Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Other Indications
6.3. Global Smart Inhalers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare Settings
Other End-Users

7. Smart Inhalers Market Regional And Country Analysis

7.1. Global Smart Inhalers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Smart Inhalers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Inhalers Market

8.1. Asia-Pacific Smart Inhalers Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Inhalers Market

9.1. China Smart Inhalers Market Overview
9.2. China Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Inhalers Market

10.1. India Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Inhalers Market

11.1. Japan Smart Inhalers Market Overview
11.2. Japan Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Inhalers Market

12.1. Australia Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Inhalers Market

13.1. Indonesia Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Inhalers Market

14.1. South Korea Smart Inhalers Market Overview
14.2. South Korea Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Inhalers Market

15.1. Western Europe Smart Inhalers Market Overview
15.2. Western Europe Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Inhalers Market

16.1. UK Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Inhalers Market

17.1. Germany Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Inhalers Market

18.1. France Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Inhalers Market

19.1. Italy Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Inhalers Market

20.1. Spain Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Inhalers Market

21.1. Eastern Europe Smart Inhalers Market Overview
21.2. Eastern Europe Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Inhalers Market

22.1. Russia Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Inhalers Market

23.1. North America Smart Inhalers Market Overview
23.2. North America Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Inhalers Market

24.1. USA Smart Inhalers Market Overview
24.2. USA Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Inhalers Market

25.1. Canada Smart Inhalers Market Overview
25.2. Canada Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Inhalers Market

26.1. South America Smart Inhalers Market Overview
26.2. South America Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Inhalers Market

27.1. Brazil Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Inhalers Market

28.1. Middle East Smart Inhalers Market Overview
28.2. Middle East Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Inhalers Market

29.1. Africa Smart Inhalers Market Overview
29.2. Africa Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Inhalers Market Competitive Landscape And Company Profiles

30.1. Smart Inhalers Market Competitive Landscape
30.2. Smart Inhalers Market Company Profiles
- 30.2.1. Novartis AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. AstraZeneca Plc
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. GlaxoSmithKline Plc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. 3M Health Care Limited
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Boehringer Ingelheim International GmbH
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Smart Inhalers Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.
31.2. Berry Global Group Inc.
31.3. Aptar Group Inc.
31.4. Lupin Limited
31.5. Findair Sp.Z.o.o.
31.6. OPKO Health Inc.
31.7. Nemera France SAS
31.8. Vectura Group Limited
31.9. Propeller Health
31.10. Inspiro Medical Ltd.
31.11. Biocorp Production
31.12. Cohero Health Inc.
31.13. Pneuma Respiratory Inc.
31.14. Amiko Digital Health Limited
31.15. Cognita Labs LLC

32. Global Smart Inhalers Market Competitive Benchmarking

33. Global Smart Inhalers Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Inhalers Market

35. Smart Inhalers Market Future Outlook and Potential Analysis

35.1 Smart Inhalers Market In 2028 - Countries Offering Most New Opportunities
35.2 Smart Inhalers Market In 2028 - Segments Offering Most New Opportunities
35.3 Smart Inhalers Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer